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Title: Group cognitive behavioural therapy for stroke survivors with depression and 
their carers 
Abstract 
Background: Depression in stroke survivors is common, leads to poorer outcomes and 
often not treated.  A group cognitive behavioural therapy (CBT) program (Brainstorm) 
for stroke survivors with depression, and their carers has been running as part of usual 
care since 2007. 
Objective: To evaluate the implementation and acceptability of Brainstorm, a closed 
group intervention consisting of up to 10 sessions of education, activity planning, 
problem solving and thought challenging.  
Methods: Participating stroke survivors and their carers complete assessment measures 
at baseline, post-treatment and 1-month and 6-months follow-up.  A mixed models for 
repeated measures data was conducted with depression and anxiety scores for stroke 
survivors (Beck Depression Inventory-II; Hospital Anxiety and Depression Scale) and 
the assessment of depression, anxiety and carer burden for carers.  Acceptability was 
assessed by session attendance and written and open participant feedback upon 
completion of the program. 
Results: Forty-eight community dwelling stroke survivors and 34 carers attended 
Brainstorm, with a median attendance of 88% of sessions. Follow-up assessments were 
completed by 77% (post-treatment), 46% (1-month) and 38% (6-month) of stroke 
survivors. Stroke survivors’ depression scores decreased from baseline to post-treatment 
(p<.001); maintained at 1-month (p<.001) but not at 6-month (p=.056). Anxiety scores 
decreased between baseline and 1-month (p=.013).  Carer burden, depression and 
anxiety scores at 1-month and 6-month follow-up, for carers, were all reduced when 
compared with baseline (p<.05).   
Conclusion: The Brainstorm group intervention for depression in stroke survivors 
appears to have been effectively implemented and is acceptable to stroke survivors and 
carers.   
Keywords: Cognitive behaviour therapy, depression, group therapy, stroke, anxiety, 
carers  
Introduction 
Approximately one-third of stroke survivors experience depression in the year 
following stroke1 which may impede rehabilitation, reduce socialisation and increase 
mortality risk.2-3   The management of stroke survivors’ behaviours and provision of 
emotional support has been associated with negative caregiver outcomes, such as 
reduced social functioning, well-being and physical health4 and increased caregiver 
emotional distress.5 
Reliable empirical evidence to guide clinical management of post-stroke depression is 
limited.6  A Cochrane review provided tentative support for the use of antidepressant 
medication for depression in stroke survivors; however caution was advised due to side 
effects and unknown risks associated with these medications.6  Potential benefit of 
psychotherapeutic interventions for depression treatment post-stroke has been difficult 
to ascertain due to small number of studies6 and methodological limitations including 
small sample size, lack of treatment manual and poor experimental design.   
Cognitive behaviour therapy (CBT) is a relatively brief, structured psychotherapy 
considered particularly effective in the treatment of mild to moderate depression in the 
general population7-8 and with depressed older adults.9  While individually delivered 
CBT has been shown to reduce depressive symptoms in stroke survivors,10-11 a 
randomised controlled trial failed to demonstrate superiority over an attention control or 
standard care.12  However, more recently a behavioural intervention was found to be 
effective in treating depression in stroke survivors with aphasia.13   Further studies are 
needed to develop and evaluate effective psychotherapeutic interventions for depression 
in stroke survivors.  
Group CBT is estimated to cost half that of individually administered therapy and is 
able to treat more people using the same resources.14  This makes group CBT attractive 
for services with limited resources, including stroke services that may have minimal 
access to clinical psychologists.15  
A group CBT program, Brainstorm, was developed for outpatient stroke survivors 
experiencing symptoms of depression.  This program was adapted from an existing 
group CBT program for cardiac rehabilitation outpatients.16-17 As part of the program, 
participants completed pre- and end of treatment outcome measures, with follow-up at 1 
and 6 months post treatment.   
 
The aim of the present study was to examine the feasibility of the Brainstorm group 
CBT program and acceptability for stroke survivors experiencing symptoms of 
depression and their carers.   
The primary hypothesis was that Brainstorm could be successfully implemented and 
would be acceptable to stroke survivors and their carers. The secondary hypotheses 
were that the group CBT intervention would result in lower depression scores for stroke 
survivors at the end of treatment (indicating improved mood) and that this reduction 
would be maintained at 1 month and 6 month post intervention.  It was expected that 
stroke survivors would demonstrate an overall reduction in symptoms of anxiety, while 
carers would demonstrate reductions in depression, anxiety and carer burden.  
 
Methods 
Design and setting 
Data were collected as part of a service evaluation of a clinical program. No control 
group was used.  Data were available from eight Brainstorm CBT programs conducted 
between March 2007 and June 2013.  
Participants and procedures 
The program was open to stroke survivors aged ≥18 years with depressive symptoms 
(as determined by their referring clinician), with intact receptive communication, able to 
read, communicate verbally and complete ‘tick’ boxes on questionnaires independently.  
Exclusion criteria included major cognitive impairment or dementia; or non-English 
speaking.  Suitability for the group program was determined via clinical judgement of 
referring clinicians and group facilitators. No screening tests for mood disorders were 
routinely used to assess eligibility, nor was antidepressant usage documented. 
Participants either self-referred or were referred by health professionals within 
government and non-government inpatient and outpatient stroke services.  All interested 
and eligible stroke survivors were offered treatment.  Stroke survivors were asked to 
attend the group with a support person (“carers”), but were not excluded if they chose to 
attend alone. Carers, while not the target group, were included to benefit from CBT 
strategies personally and to assist stroke survivors in their recall and use of strategies 
outside of the group. 
Individual baseline assessment occurred at the initial group session and the end of 
treatment assessment at the final Brainstorm session.  Participants provided verbal and 
anonymous written feedback during the final session.  Participants were also mailed 
questionnaires to complete at 1 and 6 months post-intervention.   
Intervention 
Brainstorm is a closed group CBT program consisting of between 7-10 sessions of 2-3 
hours duration.  The first group programs consisted of 7 or 8 weekly sessions.  The 
program was extended by two sessions for groups 6-8 (6 weekly sessions, followed by 2 
fortnightly sessions, and then 2 sessions a month apart) as preliminary data analysis 
suggested a loss of improvement in depressive symptoms by 6 months post-treatment.  
The additional sessions allowed more time for the delivery of the same content.  Groups 
were facilitated by either 2 clinical psychologists or a clinical psychologist and a social 
worker or occupational therapist. 
The cognitive and behavioural component of the Brainstorm program focuses upon 
improving mood by increasing activities, motivation and socialisation and in developing 
more adaptive cognitions.  Brainstorm uses a manualised ‘tool kit’ approach; likening 
CBT strategies to maintenance tasks (Table 1).  Each session included a program 
overview; review of homework from the past session; new information and new 
homework tasks; and a session summary.  CBT techniques included: psycho-education, 
mood monitoring, activity monitoring and planning, thought monitoring and 
challenging.  Problem solving skills included brainstorming, structured problem 
solving, goal setting, prioritising and motivating tools.  Participants were encouraged to 
use these skills to deal with depression, anxiety and problems with day to day living.  
Some separate group time for stroke survivors and carers provided carers with a 
confidential arena to discuss difficulties in providing support for stroke survivors and 
allowed CBT strategies that targeted stroke survivor and carer-specific concerns.   
All participants received a manual in the first session that included session information, 
examples, additional reading and a separate ‘daily diary’ for homework tasks.  The 
participants’ manuals were written in large font with double-spaced lines and tick-box 
options suitable for stroke survivors with a range of physical and cognitive disabilities 
and those with mild dysphasia, and approved by a speech pathologist with stroke 
expertise.  
Measures 
Stroke survivors completed BDI-II, HADS anxiety and depression subscales (HADSA, 
HADSD) at each assessment.  Carers completed BDI-II, HADSA, HADSD and the 
Oberst Caregiving Burden Scale (OCBS).  Participants received feedback on their 
depression and anxiety scores at the initial and final treatment sessions. 
As the outcome measures were given as part of a service evaluation project, completion 
of the measures was deemed sufficient consent, as participants who completed the 
measures did so with full knowledge that the results would be used to evaluate the 
program.  Analysis of the outcome data and publication and dissemination of results 
were approved by the relevant ethics committees.  
Participant feedback 
Acceptability was assessed by session attendance and participant feedback.  A separate 
process evaluation was not conducted.  Participants provided anonymous written and 
open feedback about the Brainstorm group during their final session.  Participants 
responded to 10 questions using a 5-point Likert scale, adapted from Edelman et al.18  
Responses ranged from 1 (not at all); to 5 (very much) on questions relating to 
facilitation, enjoyment, benefits of group setting and usefulness of the manual and daily 
diary.  Participants provided open feedback about the positives and negatives of the 
program and were able to suggest changes. 
Depression and anxiety 
The 21 item BDI-II19 and 14 item HADS20 are both widely used and validated measure 
of self-reported depression and anxiety in people with stroke.21-22  Each item on the 
BDI-II is scored from 0-3 (total score range 0-63) with recommended severity 
categories of depression: Minimal (0-13); Mild (14-19); Moderate (20-28); and Severe 
(29-63).19  The HADS has a 7-item anxiety subscale (HADSA) and a 7-item depression 
subscale (HADSD).  Each item is scored from 0-3 (total subscale score range 0-21), 
with recommended severity categories of: Minimal (0-7); Mild (8-10); Moderate (11-
13); and Severe (14-21) depression or anxiety. 
Caregiver Burden 
The 15 item Oberst Caregiving Burden Scale (OCBS, 4) assesses time requirement and 
difficulty of tasks provided by caregivers, rating the time involved in a specific task 
(ranging from none to a great amount, scored 1-5); and the difficulty of performing the 
task (ranging from not difficult to extremely difficult, scored 1-5).  Summed scores 
provide total sub-scores for time and difficulty (ranging from 15-75) with higher scores 
indicating greater time spent or difficulty with tasks.4  
Analysis 
Data were analysed with IBM SPSS Statistics for Windows (version 20.0; SPSS, 
Chicago, IL, USA).  Significance reported a priori as α = .05.  Data deemed missing at 
random was dealt with according to questionnaire-specific guidelines.4,22  Missing data 
were imputed, where permissible, by averaging individual participants’ scores within a 
subscale.   
Linear mixed models were created for all outcomes to determine changes from baseline 
to end of treatment, and again at 1 and 6 months post-treatment.  This approach to 
analysing repeated measures data ensured all participants were included in the analysis.  
Models were tested with 3 covariance options (Compound Symmetry; Toeplitz and 
Unstructured/General), with best fit determined by the lowest Akaike’s Information 
Criteria (AIC) and Schwartz’s Bayesian Criterion (BIC) values.   
Results 
Participant Characteristics 
Eighty-two participants started the program, including 48 stroke survivors (59%; n=31 
male; mean age 66.0, SD 11.6 years; median time since stroke 15 months; 71% one 
prior stroke, 29% 2-3 prior strokes) and 34 carers (41%; n=7 male; mean age 62.8, SD 
15.0 years).  Thirty-seven (77%) stroke survivors and 24 (71%) carers completed the 
end of treatment assessment (Figure 1).   
Median attendance was 88% for all stroke survivors with 17 (35%) attending all 
sessions; 12 (25%) missing only one session; and 5 (10%, from different groups) 
attending one session only. For those who attended 25% or less of sessions, there were 
no significant differences in proportions of males, or baseline BDI-II, HADSA or 
HADSD scores, although of these participants, the average age of stroke survivors and 
carers was 60 years, 7 years younger than those who attended most sessions (p=.017).  
As the program was part of a clinical service, participants were not contacted to 
ascertain reasons for discontinuation.  
 
Participant Feedback 
Fifty-three participants (87%) provided anonymous feedback and reported high 
satisfaction with the program.  All respondents rated “How helpful was it being in a 
group with people in a similar situation” either 4 (“quite a lot”) or 5 (“very much”).  
Questions about enjoyment, helpfulness and leader quality had average ratings >4.  The 
completion and ease of homework items (3 questions) had the lowest ratings, where 
responses ranged from 1 ‘not at all’ (1 participant) to 5 ‘very much’ (43 participants) 
with a median response of 4 ‘quite a lot’.  Nineteen percent of participants rated 
homework as 1 or 2, indicating that this part of the manual could be improved.   
Suggestions for changes (obtained from open feedback at the final session) were 
primarily practical (program location; easier building access; reduced travel time).  
Resources did not allow for a full qualitative exploration of participant feedback.  
 
Mixed Models Analysis for Stroke Survivors 
Ages, gender, numbers of strokes, time since stroke or percentage of sessions attended 
were not significant in the models for BDI-II, HADSD and HADSA.  HADSD scores 
were not significantly different for the 8 CBT groups.  Baseline BDI-II and HADSA 
scores showed differences between groups (group 4 having significantly higher and 
group 7, significantly lower scores; Table 2). 
Depression 
Linear mixed model analysis found significant effects on the BDI-II for time 
(F(3,61.64)=9.85, p<.001) and group (F(7,42.42)=2.26, p=.048) but groups did not 
change differently over time (Table 3).  Post-treatment and 1-month BDI-II scores were 
significantly lower than baseline (p<.001), while 6-month BDI-II scores were not (p = 
0.056).   
Stroke survivors’ BDI-II scores were categorised into severity ratings (Table 3).  At 
baseline, 59% of stroke survivors had BDI-II scores within the moderate or severe 
categories, with 30% in these categories at end of treatment.  Stroke survivors’ mean 
baseline scores on the BDI-II were categorised as moderate.  Stroke survivors with 
more severe depression showed the greatest degree of change in scores from baseline to 
post-treatment.23   
Mean HADSD scores changed significantly over time (F(3,78.49)=3.96, p=.011).  
HADSD scores at post-treatment (p=.001) and 1-month (p=.039), but not 6-months 
(p=.082), were significantly lower than at baseline. 
Anxiety 
A linear mixed model analysis testing time, group-attended and their interaction using 
fixed effects found significant effects on mean HADSA for time (F(3,60.93)=3.34, 
p=.025) and group (F(7,42.39)=2.30, p=.045) but not for their interaction. One-month 
HADSA post treatment scores were significantly lower than baseline (p=.013), while 
post-treatment (p=.068) and 6-month scores were not.  
Mixed Model Analysis for Carers 
Scores on BDI-II (p=.004) decreased significantly from baseline to 1-month (p=.014) 
and 6-month (p=.001).  There was no significant change over time for carers’ HADSD 
scores.  Mean HADSA scores decreased significantly over time (p=.020) from baseline 
to 1-month (p=.007) and 6-month (p=.016). 
Scores on the OCBS Time (p=.008) decreased significantly from baseline to 1 month 
(p=.020) and 6 months (p=.002).   OCBS Difficulty scores (p=.002) also similarly 
decreased at 1 month (p=.003) and 6 months (p=.001)(Table 4). 
Carers’ 6 month post-treatment scores were significantly lower than the end of 
treatment scores on the BDI-II (p=.013), OCBS Time (p=.010) and OCBS Difficulty 
(p=.021) subscales. 
Discussion 
We evaluated the implementation and acceptability of a group cognitive behavioural 
therapy (CBT) program (Brainstorm) for stroke survivors with depression, and their 
carers.  Forty-eight stroke survivors (and their carers) were enrolled into 8 groups of the 
program; most attended >80% of sessions offered. Anonymous feedback indicated that 
the group format was appealing; potentially due to being around others in a similar 
situation, development of mutual support, and increased socialisation.  Depression 
scores at the end of Brainstorm were significantly lower than baseline. Demographic 
characteristics such as age, gender, number of strokes suffered, time since stroke and 
percentage of sessions attended were not associated with depression or anxiety scores 
over time in stroke survivors.  This reduction in depression scores was sustained at 1-
month but not 6-months post treatment indicating that any benefits of the Brainstorm 
program ceased soon after group attendance stopped. 
This study is one of very few evaluating the implementation and acceptability of group 
CBT for depression in stroke survivors. Gurr24 reported a decrease in depression and 
anxiety scores for 16 stroke survivors after up to three sessions of CBT and relaxation in 
an open group format within an acute stroke rehabilitation unit. We did not replicate 
their finding of a greater reduction in anxiety scores, possibly because the current group 
CBT intervention was targeted toward reduction of depression rather than anxiety. 
The improvement in stoke survivors’ depression was maintained at 1 month post 
treatment but not sustained.  Drummond and Walker25 conducted a randomised 
controlled trial of a program designed to increase stroke survivors’ leisure activities, and 
reported improvement in psychological wellbeing at 3 months which also did not persist 
at 6 months.  The 6 month follow-up data in the current study came from a very small 
sample (n=18).  Further research is required to confirm whether the benefits of 
Brainstorm persist beyond one month. 
Stroke survivors’ mean baseline scores on the BDI-II were categorised as moderate, 
which is within the severity range considered to potentially benefit from group CBT 
interventions.7  
It was interesting to note that depression and anxiety scores for carers and perceived 
carer burden only decreased after the Brainstorm program was completed.  This delayed 
reduction in scores may occur for several reasons.  Stroke survivors’ symptoms may 
have stabilised over time resulting in a decrease in the time and difficulty of tasks 
required of carers.  Carers may have developed increased self-confidence in providing 
care over time.  Alternatively, the Brainstorm program may have provided carers with 
CBT strategies to deal with their own mood, resulting in a flow-on effect of changing 
their perception of carer burden.   
There are several limitations of the current study.  This study had a small sample, and as 
it was an evaluation of existing service data, there was no control group.  An inclusive 
approach to group admittance meant that some stroke survivors with minimal 
depressive symptoms were included, and group members had a broad range of levels of 
impairments.  There was no evaluation of history of depression before stroke or formal 
diagnostic assessment of depression before entry to the Brainstorm program.  Further, 
documentation of current use of antidepressant medication was not available, nor was 
there a measure of stroke severity. localisation or assessment of treatment integrity.  
Finally, as follow-up questionnaires were posted, the rate of return was low.  
The low recruitment rates into the Brainstorm program may reflect referral barriers 
since Brainstorm was open to all inpatient and outpatient services.  In fact, 
approximately 1000 strokes occur in the catchment area on an annual basis which 
suggests that larger numbers of stroke survivors would be eligible for Brainstorm. This 
may indicate a need for routine depression screening of people after stroke.  There were 
also barriers explicitly expressed by stroke survivors and carers such as difficulty for 
stroke survivors in physically attending the group due to limited mobility, lack of 
transport or access to the facilities.  In addition, some stroke survivors may prefer other 
types of treatment over a group therapy program.  In depth interviews with participants 
at the final session may provide further information regarding group acceptability. 
This study provides justification for the conduct of a randomised controlled trial to 
determine whether the benefits of the Brainstorm program occur above and beyond that 
of usual care control group, or ideally, an attention control group.  Participants in a 
depression treatment trial would be systematically screened for depression and only 
those scoring above an agreed cut point on a standard screening instrument, or those 
with a DSM diagnosis, would be eligible for entry.  This would also provide an 
opportunity to demonstrate the degree to which depressive symptom frequency and 
severity reduced pre-post intervention in comparison with controls.  Our results also 
indicate that the inclusion of carers is recommended.  In addition, given a Cochrane 
review26 has provided some evidence of effectiveness of talking therapies as a 
prevention strategy for depression after stroke, a second trial could examine the role of 
the Brainstorm program as a prevention strategy for post stroke depression. 
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Table 1 Brainstorm session content 
 
Session Number Session Title Content 
1 Introduction.  So tell me what is this all 
about? 
• Group introductions • Symptom screening and 
feedback (BDI-II, HADS) • Introduction to mood 
monitoring 
2 Figuring out the problem: working out 
what makes you feel bad. 
• The impact of stroke • Stroke and mood • Psychoeducation 
(depression/anxiety) • Goal setting 
3 If it aint broke, don’t fix it: working out 
what makes you feel good. 
• Link between activity and 
mood • Brainstorming – problem 
solving • Activity planning 
4 If it is broke... Part 1 Pros and cons for 
change. 
• Problem solving • Links between thoughts, 
feelings and actions. 
5 If it is broke... Part 2: Overcoming barriers 
to change 
•  Barriers to change • Overcoming barriers • Thought challenging 
6 Helping change happen: Resources and 
supports 
• Further problem solving 
with a focus on increasing 
motivation. • Managing conflict • Finding resources and 
supports 
7 - 9 Dealing with the squeaky bits: Common 
fears and problems 
 
Discussion of topics of interest from group 
participants 
• Sleeping problems • Dealing with emotional 
lability • Dealing with anxiety and 
panic • Information for carers 
10 DIY or professional needed: Where to 
from here? 
 
 
 
 
BDI-II: Beck Depression Inventory 
HADS: Hospital Anxiety and Depression 
Scale. 
• Review of goal setting and 
achievements. • Review of main messages 
and tools. • Symptom re-screening and 
feedback (BDI-II, HADS). • Options for further 
assistance. • Discussion and feedback. 
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Table 2.Baseline mean scores and standard error scores for stroke survivors for BDI-II and HADSA according to group they attended 
 
Group1 Group 2 Group 3 Group 4 Group 5 Group 6 Group 7 Group 8 
 
No. stroke survivors/ group 
 
6 
 
5 
 
6 
 
4 
 
5 
 
6 
 
7 
 
9 
 
        
BDI-II 
Mean(SE) 
 
17.10(3.84) 
 
 
17.86(4.26) 
 
22.24(3.91) 
 
30.41(4.77)* 
 
23.33(4.71) 
 
19.74(3.10) 
 
11.09(3.60)* 
 
13.47(3.33) 
 
        
HADSA 
Mean(SE) 
 
8.44(1.51) 
 
 
6.23(1.65) 
 
8.84(1.51) 
 
11.43(1.84)* 
 
10.44(1.84) 
 
9.35(1.53) 
 
4.61(1.39)* 
 
6.20(1.28) 
*Significance level p<.05  
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Table 3.Estimated marginal means for stroke survivors for BDI-II, HADSD and HADSA at assessment time points 
  
Follow-Up 
 
Measure Baseline 
(n=46) 
End of Treatment 
(n=37) 
1 Month post 
treatment 
(n=22) 
6 Months post 
treatment 
(n=18) 
p 
 
        
BDI-II 
Mean (SE) 
 
23.66 (1.54) 
 
17.33 (1.64)* 
 
16.14(2.09)* 
 
19.48 (2.27) 
 
Time   F(3,61.64)= 9.85 (p<.001)* 
Group F(7,42.42)= 2.26 (p=.048)* 
BDI-II Severity % 
Minimal(0-13) 
Mild (14-19) 
Moderate (20-28) 
Severe (29-63) 
 
24% 
17% 
35% 
24% 
 
35% 
35% 
14% 
16% 
 
64% 
5% 
27% 
5% 
 
56% 
11% 
6% 
28% 
 
HADSD 
Mean (SE)  
 
8.54 (0.63) 
 
6.85 (0.66)* 
 
7.23 (0.75)* 
 
7.32 (0.81) 
 
Time F(3,78.49) = 3.96 (p=.011)* 
HADSA 
Mean (SE) 
 
9.28 (0.62) 
 
8.18 (0.66) 
 
7.23 (0.86)* 
 
7.87 (0.95) 
 
Time F(3,60.93)=3.34 (p=.025)* 
Group F(7,42.39)=2.30 (p=.045)* 
*Significance level p<.05 
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Table 4.Estimated marginal means for carers for OCBS Time and Difficulty subscales, BDI-II, HADSD and HADSA at assessment time points 
  
Follow-Up Significance 
Measure Baseline End of Treatment 1 Month post 
treatment 
6 Months post 
treatment 
p 
 
OCBS Time 
Mean (SE) 
OCBS Difficulty 
Mean (SE) 
BDI-II 
Mean (SE) 
 
(n= 29) 
43.81 (2.27) 
 
29.99 (1.90) 
(n=34) 
11.62 (1.31) 
 
(n=21) 
42.36 (2.46) 
 
27.28 (2.06) 
(n=24) 
9.83 (1.51) 
 
(n=12) 
37.00 (2.96)* 
 
22.89 (2.49)* 
(n=14) 
6.93(1.87)* 
 
(n=11) 
34.10 (3.06)* 
 
21.74 (2.49)* 
(n=11) 
4.55 (1.99)* 
 
 
F(3,40.22) = 4.52 (p=.008)* 
 
F(3,41.38) = 5.93 (p=.002)* 
 
F(3,48.01)= 4.99 (p=.004)* 
HADSD 
Mean (SE) 
 
4.65 (0.59) 
 
4.20 (0.66) 
 
3.42 (0.78) 
 
3.20 (0.85) 
 
F(3,51.18) = 1.54 (p=.214) 
 
     
HADSA 
Mean (SE) 
 
7.12 (0.61) 
 
6.41 (0.69) 
 
4.78 (0.84)* 
 
4.84 (0.93)* 
 
F(3,51.46)=3.57 (p=.020)* 
*Significance level p<.05
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Figure Captions:  
Figure 1. Flow diagram of participant numbers at baseline, end of treatment assessment, 
1-month and 6-months post treatment.  
 
 
 
